Loading company…
Personalis Inc., based in Menlo Park, develops cancer diagnostics such as the NeXT Personal ctDNA test for recurrence detection.
Founded in 2011 in Menlo Park, California, Personalis Inc. provides diagnostic testing to detect cancer recurrence, using ultra-sensitive circulating tumor DNA analysis through its NeXT Personal assay. The assay is sold to oncologists, healthcare institutions and biopharma partners. The company has raised a total of USD 150.10 mn, most recently in a Private Placement/Follow on in January 2021. It was co-founded by Atul Butte, Euan Ashley and Russ Altman and is led by CEO John West.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in